First phase release coefficient of insulin in subjects with normal glucose tolerance on glucose infusion analyzed by computer simulation

BioSystems

Volumn 91, Issue 1, 2008, Pages 146-157

  Huang, Chien Ning ^a,b   Chou, Wen Chih ^c   Lin, Li Yun ^d   Peng, Chiung Chi ^e   Chyau, Charng Cherng ^d   Chen, Kuan Chou ^f   Peng, Robert Y ^d,g  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHAOYANG UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

^e CARDINAL TIEN COLLEGE OF HEALTHCARE AND MANAGEMENT   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Glucose infusion; Insulin release; Phase fractionation coefficient

Indexed keywords

GLUCOSE; INSULIN;

BIOLOGICAL METHOD; COMPUTER SIMULATION; CYTOLOGY; GLUCOSE; HORMONE;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; COMPUTER SIMULATION; CORRELATION COEFFICIENT; GLUCOSE INFUSION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; MATHEMATICAL MODEL; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; SECRETORY GRANULE; STIMULATION;

EID: 37449031830     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biosystems.2007.08.005     Document Type: Article

References (28)

1. Bergman R.N., Finegood D.T., and Ader M. Assessment of insulin sensitivity in vivo. Endocr. Rev. 6 (1985) 45-86
2. Bergman R.N., Prager R., Volund A., and Olefsky J.M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 79 (1987) 790-800
3. Cerasi E. Aettiology of type II diabetes. In: Ashcroft F.M., and Ashcroft S.J.H. (Eds). Insulin: Molecular Biology to Pathology (1992), Oxford University Press, Oxford, UK 347-392
4. Chen M., and Porte Jr. D. The effect of rate and dose of glucose infusion on the acute insulin response in man. J. Clin. Endocrinol. Metab. 42 (1976) 1168-1175
5. Colman P.G., Stewart V., Kean J., Koschmann M., Alford F., Ward G., Deam D., and Harrison L.C. Comparison of two commonly used standard IVGTTs. Diabetes Care 15 (1992) 1053-1055
6. Cutfield W.S., Bergman R.N., Menon R.K., and Sperling M.A. The modifield minimal model: application to measurement of insulin sensitivity in children. J. Clin. Endocrinol. Metab. 70 (1990) 1644-1650
7. Darren J.M., Robert A.R., Leena H., and Robert H.C. Pancreatic β-cells secrete insulin in fast- and slow-release forms. Diabetes 55 (2006) 600-607
8. Elrick H., Stimmler L., Hlad Jr. C.J., and Arai Y. Plasma insulin response to oral and intravenous glucose administration. J. Clin. Endocr. 24 (1964) 1076-1082
9. Ezenwaka C.E., Akanji A.O., Osei K., Adejuwon C.A., O'Dorisio T.M., Cottrell D.A., and Akinlade K.S. Glucose and insulin response to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus. Diabetes Res. Clinic. Pract. 20 (1993) 175-181
10. Galvin P., Ward G., Walters J., Pestell R., Koschmann M., Vaag A., Martin I., Best J.D., and Alford F. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabetes Med. 9 (1992) 921-928
11. Gulli G., Ferrannini E., Stern M., Haffner S., and DEfronzo R.A. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41 (1992) 1575-1586
12. Henriksen J.E., Hord F.A., Handberg A., Vaag A., Ward G.M., Kalfas A., and Beck-Nielsen H. Increased glucose effectiveness in normoglycemia but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 94 (1994) 1196-1204
13. James, E.B., Ollis, D.F. (Eds.), 1986. Biochemical Engineering Fundamentals. 2nd ed. McGraw-Hill International Editions, Chemical Engineering Series, pp. 383-384.
14. Kahn S.E., Prigeon R.L., McCulloch D.K., Boyko E.J., Bergman R.N., Schwartz M.W., et al. Quantification of the relationship between insulin sensitivity and β cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42 (1993) 1663-1672
15. Lerner R.L., and Porte Jr. D. Relationships between intravenous glucose loads, insulin responses and glucose disappearance rate. J. Clin. Endocr. 33 (1971) 409-417
16. McCulloch D.K., Bingley P.J., Colman P.G., Jackson R., and Gale E.A.M. The ICARUS group. Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. Diabetes Care 16 (1993) 911-915
17. McNair P.D., Peter G., Colman P.G., Alford F.P., and Harrison L.C. Reproducibility of the first-phase insulin response to intravenous glucose is not improved by retrograde cannulation and arterialization or the use of a lower glucose dose. Diabetes Care 18 (1995) 1168-1173
18. Nesher R., and Cerasi E. Modeling phasic insulin release. Diabetes 51 Suppl. 1 (2002) S53-S59
19. Ni T.-C., Ader M., and Bergman R.N. Reassessment of glucose effectives and insulin sensitivity from minimal model analysis-a theoretical evaluation of the single-compartment glucose distribution assumption. Diabetes 46 (1997) 1813-1821
20. Osei K., and Schuster D.P. Metabolic characteristics of African descendants: a omparative study of African-Americans and Ghanaian immigrants using minimal model analysis. Diabetologia 38 (1995) 1103-1109
21. Pacini G., and Bergman R.N. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput. Meth. Prog. Biomed. 23 (1986) 113-122
22. Pacini G., Finegood D.T., and Bergman R.N. A minimal model based glucose clamp yielding insulin sensitivity independent of insulin of glycemia. Diabetes 31 (1982) 432-441
23. Polonsky K.S., Given B.D., Hirsch L., Shapiro E.T., Tillil H., Beebe C., Galloway J.A., Frank B.H., Karrison T., and Cauter E.V. Quantitative study of insulin secretion and clearance in normal and obese subjects. J. Clin. Invest. 81 (1988) 435-441
24. Porte Jr. D., and Pupo A.A. Insulin response to glucose: evidence for a two pool system in man. J. Clin. Invest. 48 (1969) 2309-2319
25. Soad M.F., Anderson R.L., Laws A., Watanabe R.M., Kades W.W., Chen Y.-D.I., Sands R.W., Pei D., Savage P.J., and Bergman R.N. For the insulin resistance atherosclerosis study. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43 (1994) 1114-1121
26. Song S.H., McIntyre S.S., Shah H., Veldhuis J.D., Hayes P.C., and Butler P.C. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J. Clin. Endocrinol. Metab. 85 (2000) 4491-4499
27. Tillil H., E. Shapiro T., Rubenstein A.H., Galloway J.A., and Polonsky K.S. Reduction of insulin clearance during hyperglycemic clamp-dose-response study in normal humans. Diabetes 37 (1988) 1351-1357
28. Ward G.M., Walters J.M., Aitken P.M., Best J.D., and Alford F.P. Effects of prolonged pulsatile hyperinsulinemia in humans-enhancement of insulin sensitivity. Diabetes 39 (1990) 501-507